Adenosine Deaminase Inhibitor EHNA Exhibits a Potent Anticancer Effect Against Malignant Pleural Mesothelioma | Zendy

Y. Nakajima | Zendy; Takeshi Kanno | Zendy; Toshio Nagaya | Zendy; Kozo Kuribayashi | Zendy; Takashi Nakano | Zendy; Akinobu Gotoh | Zendy; Tomoyuki Nishizaki | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adenosine Deaminase Inhibitor EHNA Exhibits a Potent Anticancer Effect Against Malignant Pleural Mesothelioma

Author(s) -

Y. Nakajima,

Takeshi Kanno,

Toshio Nagaya,

Kozo Kuribayashi,

Takashi Nakano,

Akinobu Gotoh,

Tomoyuki Nishizaki

Publication year - 2015

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000369674

Subject(s) - ehna , adenosine deaminase , adenosine deaminase inhibitor , apoptosis , adenosine , intracellular , tunel assay , cancer research , chemistry , pharmacology , cell culture , cell growth , medicine , biology , biochemistry , genetics

Malignant pleural mesothelioma (MPM) is an aggressive malignant tumor and an effective therapy has been little provided as yet. The present study investigated the possibility for the adenosine deaminase (ADA) inhibitor EHNA as a target of MPM treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research